Xiaoyu Hua, Jianmei Chen, Xiao Peng, Jinchi Yao, Jun Li, Zhaoyun Peng, Carmen R. Valdivia, Jishun Yang, Héctor H. Valdiva, Liang Xiao
{"title":"Opicalcin1 的膜穿透能力主要来自其主序列中的后段","authors":"Xiaoyu Hua, Jianmei Chen, Xiao Peng, Jinchi Yao, Jun Li, Zhaoyun Peng, Carmen R. Valdivia, Jishun Yang, Héctor H. Valdiva, Liang Xiao","doi":"10.1134/S1990750823600206","DOIUrl":null,"url":null,"abstract":"<p>Background: Calcin is a group of globular peptides with 33−35 AAs that penetrate the cell membrane and specially target RyRs from scorpion venoms, however, which fragment in primary sequence for its transmembrane effect is unclear yet. Methods: eight different fragments of the typical Opicalcin1 (OpiCa1) were synthesized according to the distribution of charged amino acids in primary sequence, followed by the determination of both cell penetration activity and cytotoxic. Results: In all eight OpiCa1 fragments, OpiCa1<sub>17−33</sub>, OpiCa1<sub>1−11</sub>, and OpiCa1<sub>23−33</sub> were predicted to be CPPs by CellPPD, and their predicted scores were much smaller than that of TAT, which is consistent with the proportion of basic amino acids. Further fluorescent microscopic experiments found that three fragments FITC labeled OpiCa1<sub>17−33</sub>, OpiCa1<sub>12−22</sub> and OpiCa1<sub>23−33</sub> displayed similar cell penetrating capacities to that of TAT. In contrast, flow cytometry found that FITC-OpiCa1<sub>17−33</sub> and FITC-OpiCa1<sub>23−33</sub> have even larger intracellular fluorescent intensities than that of TAT, indicating stronger cell penetrating capacity. Other OpiCa1 fragments displayed slightly cell penetrating effect, of which the fluorescent intensities were slightly larger than that of control but significantly lower than that of TAT, FITC-OpiCa1<sub>17−33</sub> and FITC-OpiCa1<sub>23−33</sub>. Moreover, although it is not ruled out the impact on cell viability, overall, all OpiCa1 fragments exhibited no or lower cytotoxicity. Conclusion: The latter half of calcin e.g. OpiCa1 in primary sequence is the main responsible fragment for its membrane penetrating ability, and is also a potential new CPP for further utilization e.g. drug delivery.</p>","PeriodicalId":485,"journal":{"name":"Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry","volume":"17 2","pages":"82 - 91"},"PeriodicalIF":0.6000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Membrane Penetrating Ability of Opicalcin1 Is Mainly Derived from the Latter Segment in Its Primary Sequence\",\"authors\":\"Xiaoyu Hua, Jianmei Chen, Xiao Peng, Jinchi Yao, Jun Li, Zhaoyun Peng, Carmen R. Valdivia, Jishun Yang, Héctor H. Valdiva, Liang Xiao\",\"doi\":\"10.1134/S1990750823600206\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Background: Calcin is a group of globular peptides with 33−35 AAs that penetrate the cell membrane and specially target RyRs from scorpion venoms, however, which fragment in primary sequence for its transmembrane effect is unclear yet. Methods: eight different fragments of the typical Opicalcin1 (OpiCa1) were synthesized according to the distribution of charged amino acids in primary sequence, followed by the determination of both cell penetration activity and cytotoxic. Results: In all eight OpiCa1 fragments, OpiCa1<sub>17−33</sub>, OpiCa1<sub>1−11</sub>, and OpiCa1<sub>23−33</sub> were predicted to be CPPs by CellPPD, and their predicted scores were much smaller than that of TAT, which is consistent with the proportion of basic amino acids. Further fluorescent microscopic experiments found that three fragments FITC labeled OpiCa1<sub>17−33</sub>, OpiCa1<sub>12−22</sub> and OpiCa1<sub>23−33</sub> displayed similar cell penetrating capacities to that of TAT. In contrast, flow cytometry found that FITC-OpiCa1<sub>17−33</sub> and FITC-OpiCa1<sub>23−33</sub> have even larger intracellular fluorescent intensities than that of TAT, indicating stronger cell penetrating capacity. Other OpiCa1 fragments displayed slightly cell penetrating effect, of which the fluorescent intensities were slightly larger than that of control but significantly lower than that of TAT, FITC-OpiCa1<sub>17−33</sub> and FITC-OpiCa1<sub>23−33</sub>. Moreover, although it is not ruled out the impact on cell viability, overall, all OpiCa1 fragments exhibited no or lower cytotoxicity. Conclusion: The latter half of calcin e.g. OpiCa1 in primary sequence is the main responsible fragment for its membrane penetrating ability, and is also a potential new CPP for further utilization e.g. drug delivery.</p>\",\"PeriodicalId\":485,\"journal\":{\"name\":\"Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry\",\"volume\":\"17 2\",\"pages\":\"82 - 91\"},\"PeriodicalIF\":0.6000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry\",\"FirstCategoryId\":\"2\",\"ListUrlMain\":\"https://link.springer.com/article/10.1134/S1990750823600206\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry","FirstCategoryId":"2","ListUrlMain":"https://link.springer.com/article/10.1134/S1990750823600206","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
The Membrane Penetrating Ability of Opicalcin1 Is Mainly Derived from the Latter Segment in Its Primary Sequence
Background: Calcin is a group of globular peptides with 33−35 AAs that penetrate the cell membrane and specially target RyRs from scorpion venoms, however, which fragment in primary sequence for its transmembrane effect is unclear yet. Methods: eight different fragments of the typical Opicalcin1 (OpiCa1) were synthesized according to the distribution of charged amino acids in primary sequence, followed by the determination of both cell penetration activity and cytotoxic. Results: In all eight OpiCa1 fragments, OpiCa117−33, OpiCa11−11, and OpiCa123−33 were predicted to be CPPs by CellPPD, and their predicted scores were much smaller than that of TAT, which is consistent with the proportion of basic amino acids. Further fluorescent microscopic experiments found that three fragments FITC labeled OpiCa117−33, OpiCa112−22 and OpiCa123−33 displayed similar cell penetrating capacities to that of TAT. In contrast, flow cytometry found that FITC-OpiCa117−33 and FITC-OpiCa123−33 have even larger intracellular fluorescent intensities than that of TAT, indicating stronger cell penetrating capacity. Other OpiCa1 fragments displayed slightly cell penetrating effect, of which the fluorescent intensities were slightly larger than that of control but significantly lower than that of TAT, FITC-OpiCa117−33 and FITC-OpiCa123−33. Moreover, although it is not ruled out the impact on cell viability, overall, all OpiCa1 fragments exhibited no or lower cytotoxicity. Conclusion: The latter half of calcin e.g. OpiCa1 in primary sequence is the main responsible fragment for its membrane penetrating ability, and is also a potential new CPP for further utilization e.g. drug delivery.
期刊介绍:
Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry covers all major aspects of biomedical chemistry and related areas, including proteomics and molecular biology of (patho)physiological processes, biochemistry, neurochemistry, immunochemistry and clinical chemistry, bioinformatics, gene therapy, drug design and delivery, biochemical pharmacology, introduction and advertisement of new (biochemical) methods into experimental and clinical medicine. The journal also publishes review articles. All issues of the journal usually contain solicited reviews.